These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1356555)

  • 21. A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.
    Kebabian JW; Britton DR; DeNinno MP; Perner R; Smith L; Jenner P; Schoenleber R; Williams M
    Eur J Pharmacol; 1992 Dec; 229(2-3):203-9. PubMed ID: 1362704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of fenoldopam.
    Nichols AJ; Ruffolo RR; Brooks DP
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.
    Downes RP; Waddington JL
    Eur J Pharmacol; 1993 Mar; 234(1):135-6. PubMed ID: 8097163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine stimulation of cAMP production in cultured opossum kidney cells.
    Cheng L; Precht P; Frank D; Liang CT
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F877-82. PubMed ID: 1691897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats.
    Meyer ME; Shults JM
    Pharmacol Biochem Behav; 1993 Oct; 46(2):269-74. PubMed ID: 7903456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
    Balmforth AJ; Yasunari K; Vaughan PF; Ball SG
    J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.
    Undie AS; Weinstock J; Sarau HM; Friedman E
    J Neurochem; 1994 May; 62(5):2045-8. PubMed ID: 7908949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
    Sidhu A; Olde B; Humblot N; Kimura K; Gardner N
    Neuroscience; 1999; 91(2):537-47. PubMed ID: 10366011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression.
    D'Aquila PS; Collu M; Pani L; Gessa GL; Serra G
    Eur J Pharmacol; 1994 Sep; 262(1-2):107-11. PubMed ID: 7813561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
    Häberle DA; Königbauer B
    J Physiol; 1991 Sep; 441():23-34. PubMed ID: 1687747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DA1 dopamine receptors in renal cortical collecting duct.
    Ohbu K; Felder RA
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of dopamine1- and dopamine2-receptor agonists on the cAMP generating system in canine coronary and renal arteries.
    Wang WZ; Zhao RR; Qin FZ
    Methods Find Exp Clin Pharmacol; 1994 Dec; 16(10):691-6. PubMed ID: 7723468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow.
    Zhao RR; Wang PH; Zhang WF; Fennell WH
    Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat.
    Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.